Jacob Thaysen — Senior VP and President of Diagnostics & Genomics Group at Agilent Technologies

Mr. Jacob Thaysen has been Senior Vice President and President of Diagnostics & Genomics Group at Agilent Technologies, Inc. since November 2014. Mr. Thaysen is responsible for the strategic direction and day-to-day management of the group, which serves laboratories in the Diagnostics and Genomics markets. He joined Dako A/S in 2007 and served as its Corporate Vice President of Research & Development since March 2011. He joined Agilent in 2012 as part of the Dako acquisition. He serves as Group President at DGG. He was vice president and general manager of the Diagnostics and Genomics business, within Agilent's former Life Sciences, Diagnostics and Genomics Group. Prior to that, he was vice president and general manager of Agilent's Genomics Solutions business. He was responsible for its overall operation, including strategic direction, project management, sales, marketing and R&D. He was a Management Consultant at Copenhagen Consulting Co. (now Quartz+Co.). He was a Founding Partner and Chief Technology Officer of Cantion. Mr. Thaysen holds Ph.D. Micro and nanotechnology; M.Sc. Applied Physics from Technical University of Denmark.